Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-21-015020

Options or other derivatives

  • CTO acquired 0 shares (grant or award)
  • CTO acquired 0 shares (option exercise)
  • CTO acquired 1,393,276 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
WACHTER ERIC PHD CTO 2021-06-17 Grant or award · 8% Secured Convertible Promissory Notes due 2021 +0 D: show line 1 in the form
WACHTER ERIC PHD CTO 2021-06-20 Option exercise · 8% Secured Convertible Promissory Notes due 2021 −0 0 D: show line 2 in the form
WACHTER ERIC PHD CTO 2021-06-20 Option exercise · Series D-1 Convertible Preferred Stock +1,393,276 1,393,276 D: show line 3 in the form
Loading xslF345X03/ownership.xml…